Implantable cardioverter-defibrillators: A long-term view

Internal Medicine Journal

Volumn 42, Issue 5, 2012, Pages 554-561

  Wilson, D ^a   Shi, B ^a   Harding, S ^a   Lever, N ^b   Larsen, P ^a  

^a WELLINGTON HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Follow up study; Implantable cardioverter defibrillator; Mortality; New Zealand; Secondary prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CARDIOVASCULAR EQUIPMENT; CONVULSIVE THERAPY; DEFIBRILLATOR; DEVICE INFECTION; DISEASE REGISTRY; DIURETIC THERAPY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MORTALITY; NEW ZEALAND; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REOPERATION; SECONDARY PREVENTION; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC INJURIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861439072     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02710.x     Document Type: Article

References (29)

1. Anon. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337: 1576-83.
2. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-54.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H etal. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-40.
4. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS etal. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-302.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS etal. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
6. Vardas PE, Auricchio A, Blanc J-J, Daubert J-C, Drexler H, Ector H etal. Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2007; 28: 2256-95.
7. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS etal. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1-62.
8. Saksena S. Federal guidelines for prophylactic ICD therapy in high risk populations for sudden cardiac death: is this a necessary course correction? J Interv Card Electrophysiol 2005; 12: 5-7.
9. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008; 52: 1111-21.
10. Kadish A, Goldberger J. Selecting patients for ICD implantation: are clinicians choosing appropriately? JAMA 2011; 305: 91-2.
11. Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004; 110: 112-6.
12. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW etal. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004; 110: 3760-5.
13. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH etal. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359: 1009-17.
14. Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H etal. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 2009; 6: 468-73.
15. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S etal. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2010; 122: 1265-71.
16. Tandri H, Griffith LS, Tang T, Nasir K, Zardkoohi O, Reddy CV etal. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm 2006; 3: 762-8.
17. Ronn F, Kesek M, Hoglund N, Jensen SM. Long-term follow-up of patients treated with ICD: benefit in patients with preserved left ventricular function. Scand Cardiovasc J 2008; 42: 125-9.
18. Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T etal. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death. Pacing Clin Electrophysiol 2009; 32: S16-20.
19. Sterlinski M, Przybylski A, Gepner K, Syska P, Maciag A, Lewandowski M etal. Over 10 years with an implantable cardioverter-defibrillator - a long term follow-up of 60 patients. Kardiol Pol 2010; 68: 1023-9.
20. van Welsenes GH, van Rees JB, Borleffs CJW, Cannegieter SC, Bax JJ, van Erven L etal. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace 2011; 13: 389-94.
21. Larsen GK, Evans J, Lambert WE, Chen Y, Raitt M. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2011; 8: 1881-6.
22. van Rees JB, Borleffs CJW, de Bie MK, Stijnen T, van Erven L, Bax JJ etal. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57: 556-62.
23. Larsen PD, De Silva P, Harding SA, Woodcock E, Lever NA. Use of implantable cardioverter defibrillators in the New Zealand context from 2000 to 2007. N Z Med J 2010; 123: 76-85.
24. Burgess SN, Harding SA, Melton IC, Lever NA, Swain AH, Shi B etal. An unmet need for implantable cardioverter-defibrillators in New Zealand. Europace 2011; 13: 1299-1303.
25. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S etal. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 1500-6.
26. Santangeli P, Pelargonio G, Russo AD, Casella M, Bisceglia C, Bartoletti S etal. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 2010; 7: 876-82.
27. Van der Velden LB, Huybrechts W, Adriaensens B, Ector J, Ector H, Willems R etal. Appropriate and inappropriate implantable cardioverter defibrillator interventions during secondary prevention. Acta Cardiol 2008; 63: 39-45.
28. Biffi M, Ziacchi M, Bertini M, Sangiorgi D, Corsini D, Martignani C etal. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 2008; 10: 1288-95.
29. Schaer BA, Koller MT, Sticherling C, Altmann D, Joerg L, Osswald S. Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 2009; 6: 1737-43.